Drug
Som001 A
Som001 A: highest development phase Phase 2, developed by Somnum Pharma Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Somnum Pharma Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| SOM001-A NCT07920185 | Phase 2 | Chronic Insomnia |
Latest
No recent events.
Follow Som001 A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.